|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
Menlo Park, California & Dallas, Texas, US
|
|
ReCode Therapeutics is an integrated genetic medicines company developing targeted, disease-modifying therapies for patients with life-limiting respiratory diseases. The Company’s diverse pipeline includes lead programs for cystic fibrosis (CF) caused by nonsense mutations, and primary ciliary dyskinesia (PCD). ReCode has developed a non-viral delivery therapeutic platform that enables it to precisely deliver its medicines safely and effectively. The Company is leveraging its lipid nanoparticle and nucleic acid technologies across multiple modalities, including mRNA-mediated replacement therapies, first-in-class tRNA NanoCorrectors for diseases caused by nonsense mutations, and gene editing. For more information, visit www.recodetx.com or contact us at [email protected].
|
ReCode Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used ReCode Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact ReCode Therapeutics customer service number call here 408-585-1700. To contact ReCode Therapeutics customer service number in your country click here to find.
Jessica Kelly is the CEO of ReCode Therapeutics. To contact Jessica Kelly email at [email protected] or [email protected]. Or you may call (650)740-7615 or 18508324932
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.